Vol. 18 No. 2 (2014)
LECTURES

Modern approaches to diagnostics and treatment of patients with pulmonary arterial hypertension

S. Ivanov
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology
Bio
T. Volkova
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology
Bio
R. Volkov
State Novosibirsk Regional Clinical Hospital
Bio
Yu. Khrustaleva
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology
Bio

Published 2014-06-10

Keywords

  • PULMONARY ARTERIAL HYPERTENSION,
  • DIAGNOSIS,
  • PAH TREATMENT

How to Cite

Ivanov, S., Volkova, T., Volkov, R., & Khrustaleva, Y. (2014). Modern approaches to diagnostics and treatment of patients with pulmonary arterial hypertension. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 18(2), 69–72. https://doi.org/10.21688/1681-3472-2014-2-69-72

Abstract

Pulmonary arterial hypertension (PAH) is a pathological condition complicating many diseases. PAH is characterized by a progressive increase in pulmonary vascular resistance (PVR) leading to the development of right ventricular failure and premature death of patients. The article describes the modern clinical classification of pulmonary hypertension and diagnostic algorithms. Also considered are basic approaches to standard therapy, results and experience in using modern drugs: endothelin receptor antagonists, prostanoids, phosphodiesterase inhibitors, as well as surgical methods of treatment.

References

  1. ACCF/AHA Expert Consensus Document on Pulmonary Hypertension. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association // Circulation. 2009. V. 119. P. 2250-2294.
  2. Lane K.B., Machado R.D. et al. // Nat. Genet. 2000. V. 26. P. 81-84.
  3. Rubin L.J. // New Eng. J. Med. 1997. V. 336 (2).
  4. ACC/AHA guidelines for the clinical application of echocardiography: a report of the American College of Cardiology // Circulation. 1997. V. 95. № 6. P. 1686-1744.
  5. Неклюдова Г.В., Калманова Е.Н. // Болезни сердца и сосудов. 2006. № 2. С. 42-50.
  6. Kitabatake A. et al. // Circulation. 1983. V. 68 (2). P. 302-309.
  7. Wilkerson J.L. // Heart. 2001. V. 85. P. 113-120.
  8. Данилов Н.М., Мартынюк Т.В., Белятко Е.А., Матчин Ю.Г., Чазова И.Е. // Consilium medicum. 2013. № 10. С. 86-90.
  9. Sitbon O., Humbert M. et al. // Circulation. 2005. V. 111. P. 3105-3111.
  10. The Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cardiology // Eur. Heart J. 2003. V. 24. P. 761-781.
  11. Горбатых Ю.Н., Ленько Е.В., Иванов С.Н. и др. // Патология кровообращения и кардиохирургия. 2011. № 1. С. 84-92.
  12. Матвеева Н.В., Нарциссова Г.П., Карпенко А.А., Чернявский М.А. // Патология кровообращения и кардиохирургия. 2013. № 1. C. 11-14.
  13. Мартынюк Т.В. // Актуальные вопросы болезней сердца и сосудов. 2007. № 4. С. 45-51.
  14. Humbert M., Sitbon O., Simonneau G. // N. Eng. J. Med. 2004. V. 351. P. 1425-1436.
  15. Gali N., Ussia G., Passarelli P. et al. // Am. J. Cardiol. 1995. V. 75 (3). P. 55A-62A.
  16. Sitbon O., Humbert M., Jas X. et al. // Circulation. 2005. V. 111. P. 3105-3111.
  17. Olschewski H. et al. // Chest. 2003. V. 124 (4). P. 1294-1304.
  18. Dimopoulos K., Inuzuka R. et. al. // Circulation. 2010. V. 121. P. 20-25.
  19. Архипова О.А., Мартынюк Т.В., Лазуткина В.К., Атауллаханова Д.М., Стукалова О.В., Данилов И.М., Самойленко Л.Е., Чазова И.Е. // Терапевтический архив. 2010. № 11. С. 1-4.
  20. Мартынюк Т.В., Архипова О.А., Кобаль Е.А., Ерусланова К.А., Данилов Н.М., Чазова И.Е. // Системные гипертензии. 2011. № 4. С. 3-7.
  21. Bonderman D., Nowotny R., Skoro-Sajer N. et al. // Chest. 2005. V. 128 (4). P. 2599-2603.
  22. Apostolopoulou S.C., Manginas A., Cokkinos D.V. et al. // Heart. 2007. V. 93 (3). P. 350-354.
  23. Gali N., Beghetti M. et al. // Circulation. 2006. V. 114 (1). P. 48-54.
  24. Humbert M. et al. // N. Eng. J. Med. 2004. V. 351. P. 1425-1436.
  25. Иванов С.Н., Волкова Т.Г. Руководство по легочной гипертензии у детей. М., 2013.
  26. Gali N., Olschewski H., Oudiz R.J. et al. // Circulation. 2008. V. 117 (23). P. 3010-3019.
  27. Elshaboury S.M., Anderson J.R. // Patient Preference Adherence. 2013. V. 7. P. 401-409.
  28. Balzer D.T., Kort H.W., Day R.W. et al. // Circulation. 2002. V. 106 (12 Suppl. 1). P. I76-81.
  29. Mahoney P. et al. // Am. J. Cardiol. 2001. V. 87 (2). P. 188-192.
  30. Schmid E. et al. // Anesth. Analg. 1999. V. 89 (5). P. 1108-1115.
  31. Szold O., Khoury W., Biderman P. et al. // Lung. 2006. V. 184 (1). P. 1-5.
  32. Rea R.S., Ansani N.T., Seybert A.L. // Ann. Pharmacother. 2005. V. 39 (5). P. 913-917.
  33. Мартынюк Т.В., Чазова И.Е. // Системные гипертензии. 2012. № 2. С. 1-6.
  34. Rubin L. et al. // CHEST. 2011. V. 140 (5). P. 1274-1283.
  35. Pepke-Zaba J. et al. // Chest. 2008. V. 133 (1). P. 183-189.
  36. Badesch D. et al. // J. Rheumatol. 2007. V. 34 (12). P. 2417-2422.
  37. Singh T. et al. // Am. Heart J. 2006. V. 151 (4). P. 851e1-855.
  38. Suntharalingam J. et al. // Chest. 2008. V. 134 (2). P. 229-236.
  39. Higenbottam T. et al. // Lancet. 1999. V. 353.
  40. Trulock E. et. al. // J. Heart Lung. Transplant. 2006. V. 25. P. 880-892.